Local Regulatory Experts
Connect with regulatory affairs consultancies specializing in this region.
Registrar Corp
Hampton, Virginia (HQ), Shenzhen, China, London, United Kingdom, Paris, France, Madrid, Spain, Hyderabad, India, Kuala Lumpur, Malaysia, Tel Aviv, Israel, Guatemala City, Guatemala, Cape Town, South Africa
A global FDA compliance firm assisting businesses in the food, medical device, drug, and cosmetic industries with registration, U.S. Agent services, labeling, and regulatory software solutions.
MedEnvoy Global
The Hague, Netherlands, London, United Kingdom, United States, Switzerland, Australia
A global regulatory compliance partner specializing in in-country representation (EC Rep, UKRP, CH Rep, US Agent) and independent importer services for medical device and IVD manufacturers. We help companies navigate complex regulations in Europe, the UK, Switzerland, and the US while maintaining supply chain flexibility.
KoBridge Co Ltd
Seoul, Korea, Lausanne, Switzerland
We offer fast, effective, and flexible solutions for medical device manufacturers needing to navigate the increasing complexity of global regulations. Their core competencies cover CE Marking, FDA 510(k)/PMA, MDSAP, and especially Korea MFDS registration and KGMP compliance. They handle active, non-active, combination, and animal-origin devices, providing services from strategic planning and dossier preparation to quality system implementation (ISO 13485) and audits.
IMed Consultancy Ltd
United Kingdom, Ireland
Helping medical device and in-vitro diagnostic companies with CE marking, quality management systems, auditing, and global registrations.
September 20, 2025
Approximately 5 minutes
Clinical Trials Regulations Enforcement Provisions in the UK
Clinical Trials Regulations Enforcement Provisions in the UK
Overview
This guidance explains the enforcement provisions included in the UK’s Clinical Trials Regulations, outlining how compliance is monitored and how contraventions can be addressed by the Medicines and Healthcare products Regulatory Agency (MHRA). It also clarifies the offences that may arise if clinical trial requirements are not followed.
Source: Clinical Trials Regulations enforcement provisions - GOV.UK (gov.uk)
Enforcement Approach
The MHRA employs a system of escalating compliance actions that begin with engagement during inspections and may escalate to formal regulatory actions where necessary. The focus is on achieving compliance with the Regulations through proportionate and pragmatic measures.
Source: Clinical Trials Regulations enforcement provisions - GOV.UK (gov.uk)
Infringement Notices and Offences
Under the amended Clinical Trials Regulations, the provisions against which an infringement notice or offence can be raised have been expanded. An infringement notice may be issued for breaches that also constitute an offence, enabling a proportionate response without immediately resorting to criminal prosecution.
Source: Clinical Trials Regulations enforcement provisions - GOV.UK (gov.uk)
MHRA’s Compliance Philosophy
Criminal prosecution is used only as a matter of last resort. The MHRA aims to work with sponsors, investigators and other stakeholders to resolve compliance issues through inspection findings, corrective actions, or warnings before pursuing legal action.
Source: Clinical Trials Regulations enforcement provisions - GOV.UK (gov.uk)
When Enforcement Might Occur
Enforcement may become necessary when there are serious breaches of the clinical trial conditions specified in the Regulations, such as failure to comply with safety reporting requirements, significant departures from an authorised protocol, or failure to maintain required documentation. In these cases, the MHRA may escalate from informal engagement to formal notices or ultimately legal prosecution.
(Source text; summary based on overall guidance.)
Purpose of these Provisions
The aim of the expanded enforcement provisions is to safeguard participant safety, uphold the integrity of clinical research, and ensure high standards of trial conduct. By clarifying how compliance is enforced, sponsors and investigators have clearer expectations for their regulatory responsibilities in the UK.
(Source text; summary based on overall guidance.)
Have a Question?
Ask our experts about this topic. We'll do our best to respond to your question.